ABEONA THERAPEUTICS INC's ticker is ABEO and the CUSIP is 00289Y107. A total of 57 filers reported holding ABEONA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,000 | -14.3% | 65,073 | -0.5% | 0.00% | 0.0% |
| Q2 2022 | $14,000 | -33.3% | 65,414 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $21,000 | -4.5% | 65,414 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $22,000 | -84.9% | 65,414 | -50.0% | 0.00% | -66.7% |
| Q3 2021 | $146,000 | +43.1% | 130,828 | +100.0% | 0.00% | -25.0% |
| Q2 2021 | $102,000 | -17.1% | 65,414 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $123,000 | +19.4% | 65,414 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $103,000 | +53.7% | 65,414 | 0.0% | 0.01% | +66.7% |
| Q3 2020 | $67,000 | -64.9% | 65,414 | 0.0% | 0.00% | -70.0% |
| Q2 2020 | $191,000 | +39.4% | 65,414 | 0.0% | 0.01% | +11.1% |
| Q1 2020 | $137,000 | -36.0% | 65,414 | 0.0% | 0.01% | -18.2% |
| Q4 2019 | $214,000 | +44.6% | 65,414 | 0.0% | 0.01% | +22.2% |
| Q3 2019 | $148,000 | -52.7% | 65,414 | 0.0% | 0.01% | -50.0% |
| Q2 2019 | $313,000 | -34.9% | 65,414 | 0.0% | 0.02% | -37.9% |
| Q1 2019 | $481,000 | +3.0% | 65,414 | 0.0% | 0.03% | -9.4% |
| Q4 2018 | $467,000 | -44.2% | 65,414 | 0.0% | 0.03% | -33.3% |
| Q3 2018 | $837,000 | -20.1% | 65,414 | 0.0% | 0.05% | -26.2% |
| Q2 2018 | $1,047,000 | +11.5% | 65,414 | 0.0% | 0.06% | +8.3% |
| Q1 2018 | $939,000 | -9.5% | 65,414 | 0.0% | 0.06% | -7.7% |
| Q4 2017 | $1,037,000 | -7.0% | 65,414 | 0.0% | 0.06% | -13.3% |
| Q3 2017 | $1,115,000 | +166.1% | 65,414 | 0.0% | 0.08% | +158.6% |
| Q2 2017 | $419,000 | +28.1% | 65,414 | 0.0% | 0.03% | +31.8% |
| Q1 2017 | $327,000 | +3.2% | 65,414 | 0.0% | 0.02% | 0.0% |
| Q4 2016 | $317,000 | -19.1% | 65,414 | 0.0% | 0.02% | -24.1% |
| Q3 2016 | $392,000 | +154.5% | 65,414 | 0.0% | 0.03% | +141.7% |
| Q2 2016 | $154,000 | -7.8% | 65,414 | 0.0% | 0.01% | -14.3% |
| Q1 2016 | $167,000 | -24.1% | 65,414 | 0.0% | 0.01% | -22.2% |
| Q4 2015 | $220,000 | -17.0% | 65,414 | 0.0% | 0.02% | -21.7% |
| Q3 2015 | $265,000 | -19.9% | 65,414 | 0.0% | 0.02% | -14.8% |
| Q2 2015 | $331,000 | – | 65,414 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,359,767 | $11,445,000 | 20.08% |
| NEXTHERA CAPITAL LP | 568,573 | $2,758,000 | 1.62% |
| Kavi Asset Management, LP | 365,600 | $1,773,000 | 1.30% |
| Opaleye Management Inc. | 400,000 | $1,940,000 | 1.14% |
| RA Capital Management | 1,142,857 | $5,543,000 | 0.78% |
| Castle Hook Partners LP | 349,800 | $1,697,000 | 0.38% |
| Cormorant Asset Management, LP | 500,000 | $2,425,000 | 0.33% |
| DAFNA Capital Management LLC | 76,800 | $372,000 | 0.33% |
| Perceptive Advisors | 842,173 | $4,085,000 | 0.29% |
| Soros Fund Management | 896,642 | $4,349,000 | 0.10% |